Review



rabbit phospho r x s t  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc rabbit phospho r x s t
    Rabbit Phospho R X S T, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 909 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit phospho r x s t/product/Cell Signaling Technology Inc
    Average 96 stars, based on 909 article reviews
    rabbit phospho r x s t - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    Cell Signaling Technology Inc rabbit phospho r x s t
    Rabbit Phospho R X S T, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit phospho r x s t/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit phospho r x s t - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc phosphorylated akt1 p akt1 rabbit polyclonal antibody
    Phosphorylated Akt1 P Akt1 Rabbit Polyclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated akt1 p akt1 rabbit polyclonal antibody/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    phosphorylated akt1 p akt1 rabbit polyclonal antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti phospho pka substrate rrxs t rabbit mab
    Anti Phospho Pka Substrate Rrxs T Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho pka substrate rrxs t rabbit mab/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    anti phospho pka substrate rrxs t rabbit mab - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti phospho pka substrate antibody
    Rabbit Anti Phospho Pka Substrate Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti phospho pka substrate antibody/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti phospho pka substrate antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti phospho
    Rabbit Anti Phospho, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti phospho/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti phospho - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc phospho pka substrates
    <t>LHCGR/PKA</t> pathway triggers phosphorylation of enzymes involved in de novo lipogenesis. A , phosphorylation of ACC1 (ACACA) Ser79 and ACLY Ser455 in the small luteal cells treated with different concentrations of LH (1–100 ng/ml) for 30 min. Data are presented as fold change and mean ± SD (n = 3–5). B , phosphorylation of ACC1 Ser79 and ACLY Ser455 in the small luteal cells treated with cAMP/PKA activator-forskolin (FSK; 10 μM) for 2 to 30 min. Data are presented as a fold change (FC) and mean ± SD (n = 3). Data normalized to total protein loaded on each lane. C , ATP production in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 10–50 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). D , cyclic AMP (cAMP) production by the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). E and F , representative blots showing phosphorylation of PKA <t>substrates</t> and content of steroidogenic proteins (STAR, CYP11A1), electron transport chain proteins or marker of mitochondria (TOM20) and PKA catalytic subunits in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μM) and then treated with LH (10 ng/ml) for 240 min. G , cyclic AMP (cAMP) production by the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). H , representative blots showing phosphorylation of PKA substrates and content of PKA catalytic subunits in the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. For all graphs ∗, ∗∗, ∗∗∗ and ∗∗∗∗ mean significant change with p < 0.05, p < 0.01, p < 0.001, and p < 0.0001. Data were analyzed by one-way ANOVA followed by the Bonferroni post hoc test. ACACA, acetyl-CoA carboxylase alpha; ACLY, ATP citrate lyase; CPT1A, carnitine palmitoyltransferase 1A; LH, luteinizing hormone; PKA, protein kinase A.
    Phospho Pka Substrates, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho pka substrates/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    phospho pka substrates - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti ppka substrate
    <t>LHCGR/PKA</t> pathway triggers phosphorylation of enzymes involved in de novo lipogenesis. A , phosphorylation of ACC1 (ACACA) Ser79 and ACLY Ser455 in the small luteal cells treated with different concentrations of LH (1–100 ng/ml) for 30 min. Data are presented as fold change and mean ± SD (n = 3–5). B , phosphorylation of ACC1 Ser79 and ACLY Ser455 in the small luteal cells treated with cAMP/PKA activator-forskolin (FSK; 10 μM) for 2 to 30 min. Data are presented as a fold change (FC) and mean ± SD (n = 3). Data normalized to total protein loaded on each lane. C , ATP production in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 10–50 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). D , cyclic AMP (cAMP) production by the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). E and F , representative blots showing phosphorylation of PKA <t>substrates</t> and content of steroidogenic proteins (STAR, CYP11A1), electron transport chain proteins or marker of mitochondria (TOM20) and PKA catalytic subunits in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μM) and then treated with LH (10 ng/ml) for 240 min. G , cyclic AMP (cAMP) production by the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). H , representative blots showing phosphorylation of PKA substrates and content of PKA catalytic subunits in the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. For all graphs ∗, ∗∗, ∗∗∗ and ∗∗∗∗ mean significant change with p < 0.05, p < 0.01, p < 0.001, and p < 0.0001. Data were analyzed by one-way ANOVA followed by the Bonferroni post hoc test. ACACA, acetyl-CoA carboxylase alpha; ACLY, ATP citrate lyase; CPT1A, carnitine palmitoyltransferase 1A; LH, luteinizing hormone; PKA, protein kinase A.
    Rabbit Anti Ppka Substrate, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ppka substrate/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti ppka substrate - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit monoclonal anti phospho pka substrate
    <t>LHCGR/PKA</t> pathway triggers phosphorylation of enzymes involved in de novo lipogenesis. A , phosphorylation of ACC1 (ACACA) Ser79 and ACLY Ser455 in the small luteal cells treated with different concentrations of LH (1–100 ng/ml) for 30 min. Data are presented as fold change and mean ± SD (n = 3–5). B , phosphorylation of ACC1 Ser79 and ACLY Ser455 in the small luteal cells treated with cAMP/PKA activator-forskolin (FSK; 10 μM) for 2 to 30 min. Data are presented as a fold change (FC) and mean ± SD (n = 3). Data normalized to total protein loaded on each lane. C , ATP production in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 10–50 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). D , cyclic AMP (cAMP) production by the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). E and F , representative blots showing phosphorylation of PKA <t>substrates</t> and content of steroidogenic proteins (STAR, CYP11A1), electron transport chain proteins or marker of mitochondria (TOM20) and PKA catalytic subunits in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μM) and then treated with LH (10 ng/ml) for 240 min. G , cyclic AMP (cAMP) production by the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). H , representative blots showing phosphorylation of PKA substrates and content of PKA catalytic subunits in the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. For all graphs ∗, ∗∗, ∗∗∗ and ∗∗∗∗ mean significant change with p < 0.05, p < 0.01, p < 0.001, and p < 0.0001. Data were analyzed by one-way ANOVA followed by the Bonferroni post hoc test. ACACA, acetyl-CoA carboxylase alpha; ACLY, ATP citrate lyase; CPT1A, carnitine palmitoyltransferase 1A; LH, luteinizing hormone; PKA, protein kinase A.
    Rabbit Monoclonal Anti Phospho Pka Substrate, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti phospho pka substrate/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit monoclonal anti phospho pka substrate - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    Image Search Results


    LHCGR/PKA pathway triggers phosphorylation of enzymes involved in de novo lipogenesis. A , phosphorylation of ACC1 (ACACA) Ser79 and ACLY Ser455 in the small luteal cells treated with different concentrations of LH (1–100 ng/ml) for 30 min. Data are presented as fold change and mean ± SD (n = 3–5). B , phosphorylation of ACC1 Ser79 and ACLY Ser455 in the small luteal cells treated with cAMP/PKA activator-forskolin (FSK; 10 μM) for 2 to 30 min. Data are presented as a fold change (FC) and mean ± SD (n = 3). Data normalized to total protein loaded on each lane. C , ATP production in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 10–50 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). D , cyclic AMP (cAMP) production by the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). E and F , representative blots showing phosphorylation of PKA substrates and content of steroidogenic proteins (STAR, CYP11A1), electron transport chain proteins or marker of mitochondria (TOM20) and PKA catalytic subunits in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μM) and then treated with LH (10 ng/ml) for 240 min. G , cyclic AMP (cAMP) production by the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). H , representative blots showing phosphorylation of PKA substrates and content of PKA catalytic subunits in the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. For all graphs ∗, ∗∗, ∗∗∗ and ∗∗∗∗ mean significant change with p < 0.05, p < 0.01, p < 0.001, and p < 0.0001. Data were analyzed by one-way ANOVA followed by the Bonferroni post hoc test. ACACA, acetyl-CoA carboxylase alpha; ACLY, ATP citrate lyase; CPT1A, carnitine palmitoyltransferase 1A; LH, luteinizing hormone; PKA, protein kinase A.

    Journal: The Journal of Biological Chemistry

    Article Title: Metabolic control of luteinizing hormone-responsive ovarian steroidogenesis

    doi: 10.1016/j.jbc.2024.108042

    Figure Lengend Snippet: LHCGR/PKA pathway triggers phosphorylation of enzymes involved in de novo lipogenesis. A , phosphorylation of ACC1 (ACACA) Ser79 and ACLY Ser455 in the small luteal cells treated with different concentrations of LH (1–100 ng/ml) for 30 min. Data are presented as fold change and mean ± SD (n = 3–5). B , phosphorylation of ACC1 Ser79 and ACLY Ser455 in the small luteal cells treated with cAMP/PKA activator-forskolin (FSK; 10 μM) for 2 to 30 min. Data are presented as a fold change (FC) and mean ± SD (n = 3). Data normalized to total protein loaded on each lane. C , ATP production in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 10–50 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). D , cyclic AMP (cAMP) production by the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μm) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). E and F , representative blots showing phosphorylation of PKA substrates and content of steroidogenic proteins (STAR, CYP11A1), electron transport chain proteins or marker of mitochondria (TOM20) and PKA catalytic subunits in the small luteal cells pretreated with ACLY inhibitor (BMS303141; 25 μM) and then treated with LH (10 ng/ml) for 240 min. G , cyclic AMP (cAMP) production by the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. Data are presented as fold change (FC) and mean ± SD (n = 3). H , representative blots showing phosphorylation of PKA substrates and content of PKA catalytic subunits in the small luteal cells with knockdown CPT1A (si CPT1A ; 50 nM) and then treated with LH (10 ng/ml) for 240 min. For all graphs ∗, ∗∗, ∗∗∗ and ∗∗∗∗ mean significant change with p < 0.05, p < 0.01, p < 0.001, and p < 0.0001. Data were analyzed by one-way ANOVA followed by the Bonferroni post hoc test. ACACA, acetyl-CoA carboxylase alpha; ACLY, ATP citrate lyase; CPT1A, carnitine palmitoyltransferase 1A; LH, luteinizing hormone; PKA, protein kinase A.

    Article Snippet: Phospho-ACLY (Ser455; #4331), phospho-ACACA (Ser79; #3661), CYP11A1 (#14217), phospho-PKA substrates (#9624), and TOM20 (#42406) antibodies were purchased from Cell Signaling Technology, Inc. Total OXPHOS Antibody Cocktail (ab110413), STAR (ab96637), ATP assay, and L-lactate assay were purchased from Abcam.

    Techniques: Phospho-proteomics, Marker, Knockdown